FDA recall D-0350-2024

SUN PHARMACEUTICAL INDUSTRIES INC · Class II · drug

Product

Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.

Reason for recall

Failed Dissolution Specifications: Out of specification for dissolution.

Distribution

Nationwide in the U.S.

Key facts

Status
Ongoing
Initiation date
2024-02-05
Report date
2024-03-06
Voluntary/Mandated
Voluntary: Firm initiated
Location
Princeton, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0350-2024